Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
Herantis Pharma Plc
Company release 30 July 2018 at 9:30 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Pekka Simula
Position: Chief Executive Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20180727055331_6
____________________________________________
Transaction date: 2018-06-13
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 320 Unit price: 6.85 EUR
Aggregated transactions
(1): Volume: 320 Volume weighted average price: 6.85 EUR
____________________________________________
Transaction date: 2018-06-15
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 150 Unit price: 6.85 EUR
Aggregated transactions
(1): Volume: 150 Volume weighted average price: 6.85 EUR
____________________________________________
Transaction date: 2018-06-19
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 253 Unit price: 6.85 EUR
Aggregated transactions
(1): Volume: 253 Volume weighted average price: 6.85 EUR
____________________________________________
Transaction date: 2018-07-27
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 293 Unit price: 7.3 EUR
(2): Volume: 10 Unit price: 7.4 EUR
Aggregated transactions
(2): Volume: 303 Volume weighted average price: 7.3033 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com